12th Oct 2021 14:26
EKF Diagnostics Holdings PLC - Cardiff-based diagnostics and central laboratory assay manufacturer - Completes acquisition of ALD Health, a Texas based PCR-focused testing laboratory business. The deal will see EKF make an initial payment of USD10 million in shares, with further performance-based payments payable over the following three years subject to the earnings before interest, tax, depreciation and amortisation performance of ADL.
EKF makes application for 8.9 million consideration shares to trading on the AIM Market of the London Stock Exchange, based on an exchange rate of USD1.37 to GBP1, expected October 14. It has a current market capitalisation of GBP356.7 million.
Current stock price: 80.10 pence
Year-to-date change: up 12%
By Josie O'Brien; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Ekf Diagnostics